Related references
Note: Only part of the references are listed.Hepatitis C Virus Entry: Protein Interactions and Fusion Determinants Governing Productive Hepatocyte Invasion
Gisa Gerold et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2020)
Hepatitis C Virus Replication
Keisuke Tabata et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2020)
Systematic review: chronic viral hepatitis and metabolic derangement
Chia-Chi Wang et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Modulation of calcium signaling pathway by hepatitis C virus core protein stimulates NLRP3 inflammasome activation
Amina A. Negash et al.
PLOS PATHOGENS (2019)
Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations: A 2019 Update
Elise J. Smolders et al.
CLINICAL PHARMACOKINETICS (2019)
Interleukin-1β Induces mtDNA Release to Activate Innate Immune Signaling via cGAS-STING
Lauren D. Aarreberg et al.
MOLECULAR CELL (2019)
Interferon-λ modulates dendritic cells to facilitate T cell immunity during infection with influenza A virus
Emily A. Hemann et al.
NATURE IMMUNOLOGY (2019)
Interferon-Stimulated Genes: What Do They All Do?
John W. Schoggins
ANNUAL REVIEW OF VIROLOGY, VOL 6, 2019 (2019)
Viral dynamics among HCV infected patients with different genotypes treated with genotypic specific or pan-genotypic direct-acting antiviral agent combinations
Stefania Paolucci et al.
INFECTION AND DRUG RESISTANCE (2019)
Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III Interferons
Adriana Forero et al.
IMMUNITY (2019)
Management of HCV patients in cases of direct-acting antiviral failure
C. Nelson Hayes et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2019)
Resistance Mutations A30K and Y93N Associated with Treatment Failure with Sofosbuvir and Daclatasvir for Hepatitis C Virus Infection Non-Responder Patients: Case Reports
Vanessa D. Costa et al.
VIRUSES-BASEL (2019)
Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis
Mousumi Khatun et al.
CELLS (2019)
Tight junction proteins in gastrointestinal and liver disease
Mirjam B. Zeisel et al.
GUT (2019)
The Burden of Chronic Hepatitis C in China From 2004 to 2050: An Individual-Based Modeling Study
Jie Wu et al.
HEPATOLOGY (2019)
Consensus recommendations for resistance testing in the management of chronic hepatitis C virus infection: Public Health England HCV Resistance Group
Daniel Bradshaw et al.
JOURNAL OF INFECTION (2019)
Stimulation of Innate Immunity by Host and Viral RNAs
Felix Streicher et al.
TRENDS IN IMMUNOLOGY (2019)
Treatment of Chronic Hepatitis C: Efficacy, Side Effects and Complications
Lisa Sandmann et al.
VISCERAL MEDICINE (2019)
RIG-I and Other RNA Sensors in Antiviral Immunity
Kwan T. Chow et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)
The role of the NLRP3 inflammasome and the activation of IL-1β in the pathogenesis of chronic viral hepatic inflammation
Adam Molyvdas et al.
CYTOKINE (2018)
Interleukin-1β Signaling in Dendritic Cells Induces Antiviral Interferon Responses
Lauren D. Aarreberg et al.
MBIO (2018)
A changing paradigm: management and treatment of the HCV/HIV-co-infected patient
Ameer Abutaleb et al.
HEPATOLOGY INTERNATIONAL (2018)
Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis
Marcus M. Muecke et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness
Ioanna E. Galani et al.
IMMUNITY (2017)
The role of Kupffer cells in hepatic diseases
Peizhi Li et al.
MOLECULAR IMMUNOLOGY (2017)
IFN-λ suppresses intestinal inflammation by non-translational regulation of neutrophil function
Achille Broggi et al.
NATURE IMMUNOLOGY (2017)
Liver macrophages in tissue homeostasis and disease
Oliver Krenkel et al.
NATURE REVIEWS IMMUNOLOGY (2017)
The p7 viroporin of the hepatitis C virus contributes to liver inflammation by stimulating production of Interleukin-1β
N. S. Farag et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Interferon lambda 4 genotypes and resistance-associated variants in patients infected with hepatitis C virus genotypes 1 and 3
Kai-Henrik Peiffer et al.
HEPATOLOGY (2016)
IFN is a potent anti-influenza therapeutic without the inflammatory side effects of IFN treatment
Sophia Davidson et al.
EMBO MOLECULAR MEDICINE (2016)
Interferon lambda 4 expression is suppressed by the host during viral infection
MeeAe Hong et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Interleukin 1α and the inflammatory process
Nelson C. Di Paolo et al.
NATURE IMMUNOLOGY (2016)
Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling
Abigail Jarret et al.
NATURE MEDICINE (2016)
Hepatitis C Virus Current and Evolving Treatments for Genotype 4
Tank Asselah et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2015)
Hepatitis regulation by the inflammasome signaling pathway
Amina A. Negash et al.
IMMUNOLOGICAL REVIEWS (2015)
Initiation and perpetuation of NLRP3 inflammasome activation and assembly
Eric I. Elliott et al.
IMMUNOLOGICAL REVIEWS (2015)
Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance
Thomas R. O'Brien et al.
JOURNAL OF HEPATOLOGY (2015)
Interferon-λ4 is a cell-autonomous type III interferon associated with pre-treatment hepatitis C virus burden
Yi-Fan Lu et al.
VIROLOGY (2015)
IFNL3 mRNA structure is remodeled by a functional non-coding polymorphism associated with hepatitis C virus clearance
Yi-Fan Lu et al.
SCIENTIFIC REPORTS (2015)
Virion-Independent Transfer of Replication-Competent Hepatitis C Virus RNA between Permissive Cells
Andrea Longatti et al.
JOURNAL OF VIROLOGY (2015)
Kinetic Differences in the Induction of Interferon Stimulated Genes by Interferon-α and Interleukin 28B Are Altered by Infection With Hepatitis C Virus
Nikolaus Jilg et al.
HEPATOLOGY (2014)
Immune Responses to HCV and Other Hepatitis Viruses
Su-Hyung Park et al.
IMMUNITY (2014)
IFNL4-ΔG Genotype Is Associated With Slower Viral Clearance in Hepatitis C, Genotype-1 Patients Treated With Sofosbuvir and Ribavirin
Eric G. Meissner et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus
Peter V. Aka et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Optimizing treatment for HCV genotype 4: PEG-IFN alfa 2a vs. PEG-IFN alfa 2b; the debate continues
Gamal Esmat et al.
LIVER INTERNATIONAL (2014)
The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs
Addle P. McFarland et al.
NATURE IMMUNOLOGY (2014)
Virus-related liver cirrhosis: Molecular basis and therapeutic options
Ji Lin et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
Ewa Terczynska-Dyla et al.
NATURE COMMUNICATIONS (2014)
HIV and HCV Activate the Inflammasome in Monocytes and Macrophages via Endosomal Toll-Like Receptors without Induction of Type 1 Interferon
Michael A. Chattergoon et al.
PLOS PATHOGENS (2014)
Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses
Ole J. Hamming et al.
EMBO JOURNAL (2013)
Innate Immune Tolerance and the Role of Kupffer Cells in Differential Responses to Interferon Therapy Among Patients With HCV Genotype 1 Infection
Daryl T. -Y. Lau et al.
GASTROENTEROLOGY (2013)
IFITM1 Is a Tight Junction Protein That Inhibits Hepatitis C Virus Entry
Courtney Wilkins et al.
HEPATOLOGY (2013)
IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction
Stephanie Bibert et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Interferon-stimulated genes and their role in controlling hepatitis C virus
Philippe Metz et al.
JOURNAL OF HEPATOLOGY (2013)
Hepatitis C Virus Induces Interleukin-1β (IL-1β)/IL-18 in Circulatory and Resident Liver Macrophages
Shubham Shrivastava et al.
JOURNAL OF VIROLOGY (2013)
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
Ludmila Prokunina-Olsson et al.
NATURE GENETICS (2013)
IL-1β Production through the NLRP3 Inflammasome by Hepatic Macrophages Links Hepatitis C Virus Infection with Liver Inflammation and Disease
Amina A. Negash et al.
PLOS PATHOGENS (2013)
Short-Range Exosomal Transfer of Viral RNA from Infected Cells to Plasmacytoid Dendritic Cells Triggers Innate Immunity
Marlene Dreux et al.
CELL HOST & MICROBE (2012)
被撤回的出版物: Hepatitis C virus activates interleukin-1β via caspase-1-inflammasome complex (Publication with Expression of Concern. See vol. 100, pg. 1342, 2019) (Retracted article. See vol. 100, pg. 1714, 2019)
Dylan Burdette et al.
JOURNAL OF GENERAL VIROLOGY (2012)
Innate Immune Cells in Liver Inflammation
Evaggelia Liaskou et al.
MEDIATORS OF INFLAMMATION (2012)
Uridine Composition of the Poly-U/UC Tract of HCV RNA Defines Non-Self Recognition by RIG-I
Gretja Schnell et al.
PLOS PATHOGENS (2012)
IL-1β Signaling Promotes CNS-Intrinsic Immune Control of West Nile Virus Infection
Hilario J. Ramos et al.
PLOS PATHOGENS (2012)
Effects of ad libitum Ingestion of Monosodium Glutamate on Weight Gain in C57BL6/J Mice
Xueying Ren et al.
DIGESTION (2011)
Fatty Acid and Endotoxin Activate Inflammasomes in Mouse Hepatocytes that Release Danger Signals to Stimulate Immune Cells
Timea Csak et al.
HEPATOLOGY (2011)
High Plasma Interleukin-18 Levels Mark the Acute Phase of Hepatitis C Virus Infection
Michael A. Chattergoon et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
The NLRP3 Inflammasome Detects Encephalomyocarditis Virus and Vesicular Stomatitis Virus Infection
Jayant V. Rajan et al.
JOURNAL OF VIROLOGY (2011)
A diverse range of gene products are effectors of the type I interferon antiviral response
John W. Schoggins et al.
NATURE (2011)
Pattern Recognition Receptors and the Innate Immune Response to Viral Infection
Mikayla R. Thompson et al.
VIRUSES-BASEL (2011)
Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study
Andri Rauch et al.
GASTROENTEROLOGY (2010)
Quantitative expression of RIG-like helicase, NOD-like receptor and inflammasome-related mRNAs in humans and mice
Maciej Lech et al.
INTERNATIONAL IMMUNOLOGY (2010)
Molecular Mechanism of NLRP3 Inflammasome Activation
Chengcheng Jin et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
Inflammasome-mediated regulation of hepatic stellate cells
Azuma Watanabe et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Inflammasome recognition of influenza virus is essential for adaptive immune responses
Takeshi Ichinohe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Toll-Like Receptor 3 Mediates Establishment of an Antiviral State against Hepatitis C Virus in Hepatoma Cells
Nan Wang et al.
JOURNAL OF VIROLOGY (2009)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
David L. Thomas et al.
NATURE (2009)
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Vijayaprakash Suppiah et al.
NATURE GENETICS (2009)
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
NATURE GENETICS (2009)
Immune responses during acute and chronic infection with hepatitis C virus
Shigeaki Ishii et al.
CLINICAL IMMUNOLOGY (2008)
Interferon regulatory factor-3 activation, hepatic interferon-stimulated gene expression, and immune cell infiltration in hepatitis C virus patients
Daryl T. -Y. Lau et al.
HEPATOLOGY (2008)
An important role for type III interferon (IFN-λ/IL-28) in TLR-induced antiviral activity
Nina Ank et al.
JOURNAL OF IMMUNOLOGY (2008)
Fas/FasL system, IL-1β expression and apoptosis in chronic HBV and HCV liver disease
M. Bortolami et al.
JOURNAL OF VIRAL HEPATITIS (2008)
Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA
Takeshi Saito et al.
NATURE (2008)
IFN-lambda (IFN-λ) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo
Caroline Sommereyns et al.
PLOS PATHOGENS (2008)
Type III interferon (IFN) induces a type IIFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mtogen-activated protein kinases
Zhangle Zhou et al.
JOURNAL OF VIROLOGY (2007)
Interferons α and λ inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics
Tobias Marcello et al.
GASTROENTEROLOGY (2006)
Lambda interferon (IFN-λ), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo
N Ank et al.
JOURNAL OF VIROLOGY (2006)
Viral and therapeutic control of IFN-β promoter stimulator 1 during hepatitis C virus infection
YM Loo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector
KJ Helbig et al.
HEPATOLOGY (2005)
Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease
JC Ferreon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I
R Stumper et al.
JOURNAL OF VIROLOGY (2005)
Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling
E Foy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF
K Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Kissing-loop interaction in the 3 ' end of the hepatitis C virus genome essential for RNA replication
P Friebe et al.
JOURNAL OF VIROLOGY (2005)
Structural, expression, and evolutionary analysis of mouse CIASI
JP Anderson et al.
GENE (2004)
Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-λ1 -: Similarities with type I interferon signaling
L Dumoutier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses
M Yoneyama et al.
NATURE IMMUNOLOGY (2004)
Impact of interleukin-1β genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in Japan
Y Tanaka et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Interieukin-1 beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection
Y Wang et al.
HEPATOLOGY (2003)
IL-28, IL-29 and their class II cytokine receptor IL-28R
P Sheppard et al.
NATURE IMMUNOLOGY (2003)
IFN-lambda s mediate antiviral protection through a distinct class II cytokine receptor complex
SV Kotenko et al.
NATURE IMMUNOLOGY (2003)
The inflammasome:: A molecular platform triggering activation of inflammatory caspases and processing of proIL-β
F Martinon et al.
MOLECULAR CELL (2002)
Expression of apoptosis-associated speck-like protein containing a caspase recruitment domain, a pyrin N-terminal homology domain-containing protein, in normal human tissues
J Masumoto et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2001)
Share Paper
